Furthermore, increased expression of SIRT3 upregulates p53 levels by attenuating Mdm2-mediated p53 degradation, suggesting that SIRT3 may play a critical role in inhibiting HCC progression (Zhang and Zhou, 2012). The gene discussed is TP53; the disease is hepatocellular carcinoma.